ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

PCSA Processa Pharmaceuticals Inc

1.75
0.0957 (5.78%)
15 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Processa Pharmaceuticals Inc PCSA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0957 5.78% 1.75 14:00:00
Open Price Low Price High Price Close Price Previous Close
1.61 1.61 1.75 1.75 1.6543
more quote information »

Recent News

Date Time Source Heading
12/6/202404:19EDGAR2Form DEFR14A - Revised definitive proxy soliciting materials
11/6/202422:20GLOBEProcessa Pharmaceuticals Announces Positive Efficacy Results..
29/5/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
29/5/202406:49EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/5/202406:13EDGAR2Form 8-K - Current report
22/5/202406:10EDGAR2Form S-3 - Registration statement under Securities Act of..
11/5/202406:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202422:00GLOBEProcessa Pharmaceuticals to Participate in the EF Hutton..
30/4/202422:00GLOBEProcessa Pharmaceuticals Names Dr. Steven Cha Senior Vice..
11/4/202422:00GLOBEProcessa Pharmaceuticals Presents Two Abstracts at the AACR..
28/3/202423:15GLOBEProcessa Pharmaceuticals to Present at the MedInvest Biotech..
25/3/202423:15GLOBEProcessa Pharmaceuticals to Present Data at the American..
22/2/202409:25EDGAR2Form 8-K - Current report
22/2/202400:15GLOBEProcessa Pharmaceuticals to Present at the 2024 BIO CEO &..
15/2/202405:00GLOBEProcessa Pharmaceuticals to Present at The Winter Wrap-Up..
07/2/202400:30EDGAR2Form 8-K - Current report
07/2/202400:30GLOBEProcessa Pharmaceuticals Regains Compliance with Nasdaq..
02/2/202410:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202408:22GLOBEProcessa Pharmaceuticals Announces Closing of $7.0 Million..
01/2/202408:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202402:46EDGAR2Form 8-K - Current report
30/1/202408:15EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
27/1/202401:04GLOBEProcessa Pharmaceuticals Announces Pricing of $7.0 Million..
26/1/202400:35EDGAR2Form 8-K - Current report
26/1/202400:30GLOBEProcessa Pharmaceuticals Announces Successful Completion of..
20/1/202400:00EDGAR2Form 8-K - Current report
19/1/202423:45GLOBEProcessa Pharmaceuticals Announces Expansion of NGC-Cap..
19/1/202400:30EDGAR2Form 8-K - Current report
18/1/202423:45GLOBEProcessa Pharmaceuticals to Effect a 1-for-20 Reverse Stock..
09/1/202408:30EDGAR2Form 8-K - Current report
03/1/202409:06GLOBEProcessa Pharmaceuticals to Present at the Biotech Showcase..
30/12/202300:55EDGAR2Form S-1 - General form for registration of securities under..
20/12/202301:00EDGAR2Form 8-K - Current report
20/12/202301:00GLOBEProcessa Pharmaceuticals Provides Interim Analysis from..
14/12/202301:00GLOBEProcessa Pharmaceuticals Announces Successful Phase 2..
06/12/202309:18EDGAR2Form 8-K - Current report
01/12/202300:15GLOBEProcessa Pharmaceuticals to Present at the MedInvest..
30/11/202300:15GLOBEProcessa Pharmaceuticals Issues Letter to Shareholders..
17/11/202307:10EDGAR2Form 8-K - Current report
16/11/202303:30EDGAR2Form 8-K - Current report
14/11/202308:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202306:45EDGAR2Form 8-K - Current report
14/11/202305:40GLOBEProcessa Pharmaceuticals, Inc. Mourns the Sudden Passing of..
10/11/202300:15GLOBEProcessa Pharmaceuticals to Present at the 20th Orphan Drugs..
01/11/202323:15GLOBEProcessa Pharmaceuticals Announces Formation of Oncology..
17/10/202300:15EDGAR2Form 8-K - Current report
14/10/202304:08GLOBEProcessa Pharmaceuticals to Present at the ThinkEquity..
13/10/202309:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202309:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202309:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

Delayed Upgrade Clock